PURE Bioscience Announces a New Distribution Agreement With Hydrite Chemical Company
PURE Bioscience (OTCQB: PURE) has signed a multi-year distribution agreement with Hydrite Chemical Company for the purchase and selling of SDC (silver dihydrogen citrate) products. The partnership builds upon an eight-year relationship between the companies and aims to expand the reach of PURE's antimicrobial technology through Hydrite's established distribution network.
The SDC technology works through a dual-action mechanism: silver ions deactivate structural and metabolic membrane proteins while also entering microbes as a perceived food source to denature DNA, preventing replication. Unlike traditional silver-based disinfectants with short shelf lives, SDC remains stable for several years. The agreement positions PURE to strengthen its market presence while enhancing Hydrite's product portfolio in food processing and other markets.
PURE Bioscience (OTCQB: PURE) ha firmato un accordo di distribuzione pluriennale con Hydrite Chemical Company per l'acquisto e la vendita di prodotti SDC (citrato di diidrogeno d'argento). Questa partnership si basa su una relazione di otto anni tra le aziende e mira ad ampliare la portata della tecnologia antimicrobica di PURE attraverso la rete di distribuzione consolidata di Hydrite.
La tecnologia SDC funziona attraverso un meccanismo a doppia azione: gli ioni d'argento inattivano le proteine della membrana strutturali e metaboliche mentre entrano anche nei microbi come una fonte di nutrimento percepita per denaturare il DNA, impedendo la replicazione. A differenza dei disinfettanti tradizionali a base d'argento con brevissimi periodi di conservazione, l'SDC rimane stabile per diversi anni. L'accordo posiziona PURE per rafforzare la sua presenza sul mercato, migliorando nel contempo il portafoglio prodotti di Hydrite nei settori della lavorazione degli alimenti e altri mercati.
PURE Bioscience (OTCQB: PURE) ha firmado un acuerdo de distribución a varios años con Hydrite Chemical Company para la compra y venta de productos SDC (citrato de dihidrógeno de plata). Esta colaboración se basa en una relación de ocho años entre las empresas y tiene como objetivo ampliar el alcance de la tecnología antimicrobiana de PURE a través de la red de distribución establecida de Hydrite.
La tecnología SDC funciona mediante un mecanismo de acción dual: los iones de plata desactivan las proteínas de la membrana estructural y metabólica, mientras que también ingresan a los microbios como una fuente de alimento percibida para desnaturalizar el ADN, evitando la replicación. A diferencia de los desinfectantes tradicionales a base de plata con cortas vidas útiles, el SDC se mantiene estable durante varios años. El acuerdo posiciona a PURE para fortalecer su presencia en el mercado, mientras mejora la cartera de productos de Hydrite en el procesamiento de alimentos y otros mercados.
PURE Bioscience (OTCQB: PURE)는 Hydrite Chemical Company와 SDC(은 이온 다이하이드로겐 시트르산) 제품의 구매 및 판매를 위한 다년간 유통 계약을 체결했습니다. 이번 파트너십은 두 회사 간의 8년 간의 관계를 바탕으로 하며, Hydrite의 확립된 유통 네트워크를 통해 PURE의 항균 기술의 접근성을 확장하는 것을 목표로 하고 있습니다.
SDC 기술은 이중 작용 메커니즘을 통해 작동합니다: 은 이온은 구조적 및 대사막 단백질의 기능을 비활성화하고, 미생물이 DNA를 변성하여 복제를 방지하는 영양원으로 인지되도록 미생물에 유입됩니다. 전통적인 은 기반 소독제와 달리 SDC는 여러 해 동안 안정성을 유지합니다. 이 계약은 PURE가 시장에서의 입지를 강화하고, 동시에 Hydrite의 식품 가공 및 기타 시장에서의 제품 포트폴리오를 향상시킬 수 있는 기반을 제공합니다.
PURE Bioscience (OTCQB: PURE) a signé un accord de distribution pluriannuel avec Hydrite Chemical Company pour l'achat et la vente de produits SDC (citrate de dihydrogène argenté). Ce partenariat repose sur une relation de huit ans entre les entreprises et vise à étendre la portée de la technologie antimicrobienne de PURE grâce au réseau de distribution bien établi de Hydrite.
La technologie SDC fonctionne par un mécanisme à double action : les ions d'argent inactivent les protéines de membrane structurelles et métaboliques tout en pénétrant également dans les microbes comme une source de nourriture perçue pour dénaturer l'ADN, empêchant ainsi la réplication. Contrairement aux désinfectants traditionnels à base d'argent avec de courtes durées de conservation, l'SDC reste stable pendant plusieurs années. Cet accord permet à PURE de renforcer sa présence sur le marché tout en améliorant le portefeuille de produits de Hydrite dans le traitement des aliments et d'autres marchés.
PURE Bioscience (OTCQB: PURE) hat einen mehrjährigen Vertriebsvertrag mit Hydrite Chemical Company über den Kauf und Verkauf von SDC (Silberdihydrogencitrat) Produkten unterzeichnet. Diese Partnerschaft baut auf einer achtjährigen Beziehung zwischen den beiden Unternehmen auf und zielt darauf ab, die Reichweite der antimikrobiellen Technologie von PURE durch Hydrites etabliertes Vertriebsnetzwerk zu erweitern.
Die SDC-Technologie funktioniert über einen Zweifachmechanismus: Silberionen deaktivieren strukturelle und stoffwechselaktive Membranproteine und dringen gleichzeitig in Mikroben als wahrgenommene Nahrungsquelle ein, um die DNA zu denaturieren und die Replikation zu verhindern. Im Gegensatz zu herkömmlichen silberbasierten Desinfektionsmitteln mit kurzen Haltbarkeiten bleibt SDC über mehrere Jahre stabil. Die Vereinbarung positioniert PURE, um seine Marktpräsenz zu stärken und gleichzeitig Hydrites Produktportfolio in der Lebensmittelverarbeitung und anderen Märkten zu verbessern.
- Secured multi-year distribution agreement with established industry player Hydrite
- Expands market reach through Hydrite's existing distribution network
- Builds on proven 8-year business relationship
- None.
PURE is excited to announce the signing of a strategic distribution agreement with Hydrite, a top-tier provider of complete solutions for food processing and other markets. This agreement aims to enhance the availability of PURE’s innovative products across various markets, providing customers with greater access to effective antibacterial solutions.
Tim Steffensmeier, Vice President of Sales at PURE, said, “Enlarging our partnership with Hydrite is an important step for PURE. Their established distribution network and industry experience will help us expand the reach of our SDC technology, meeting the growing need for safer and effective antimicrobial solutions.”
Hydrite, known for its commitment to quality and customer service, shares this renewed partnership's excitement. Mitch Fay, Technical Director at Hydrite, remarked, “We are thrilled to grow our eight-year relationship with PURE Bioscience under this new agreement. Their state-of-the-art SDC technology complements our portfolio perfectly, allowing us to provide our customers with effective antimicrobial solutions.”
How SDC Works
SDC kills microorganisms by two modes of action: 1) the silver ion deactivates structural and metabolic membrane proteins, leading to microbial death; 2) the microbes view SDC as a food source, allowing the silver ion to enter the microbe. Once inside the organism, the silver ion denatures the DNA, which halts the microbe’s ability to replicate and leads to its death. This dual action makes SDC highly and quickly effective against a broad spectrum of microbes. Traditional silver-based disinfectants have short shelf lives – from hours to days. SDC is a stabilized silver ion complex with a shelf life of several years. The unique bond between the silver ions in SDC allows them to remain in solution while making them more bio-available for antimicrobial action.
“This partnership underscores both companies' commitment to innovation and customer satisfaction. The collaboration is expected to strengthen PURE’s market position and further enhance Hydrite’s offerings,” added Jeff Kitchell, Vice President of Operations at PURE.
About Hydrite Chemical Company
Hydrite, founded in 1929, is one of the largest independent providers of chemicals and related services in
About PURE Bioscience, Inc.
PURE focuses on developing and commercializing our proprietary antimicrobial products, primarily in food safety. We provide best in class solutions to combat the health and environmental challenges of pathogens and hygienic control. Our technology platform is based on patented, stabilized ionic silver, and our initial products contain silver dihydrogen citrate, better known as SDC. This broad-spectrum, non-toxic antimicrobial agent formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity, and mitigation of bacterial resistance. PURE’s mailing address is 771 Jamacha Rd. #512,
Forward-looking Statements: Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Statements in this press release, including quotes from management, concerning the Company’s expectations, plans, business outlook, future performance, future potential revenues, expected results of the Company’s marketing efforts, the execution of contracts under negotiation, and any other statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are “forward-looking statements.” Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from any forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company’s failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company’s current and future products and services in the marketplace, including the Company’s ability to convert successful evaluations and tests for PURE Control and PURE Hard Surface into customer orders and customers continuing to place product orders as expected and to expand their use of the Company’s products; the Company’s ability to maintain relationships with its partners and other counterparties; the Company’s ability to generate sufficient revenues and reduce its operating expenses in order to reach profitability; the Company’s ability to raise the funding required to support its continued operations and the implementation of its business plan; the ability of the Company to develop effective new products and receive required regulatory approvals for such products, including the required data and regulatory approvals required to use its SDC-based technology as a direct food contact processing aid in raw meat processing; competitive factors, including customer acceptance of the Company’s SDC-based products that are typically more expensive than existing treatment chemicals; dependence upon third-party vendors, including to manufacture its products; and other risks detailed in the Company’s periodic report filings with the Securities and Exchange Commission (the SEC), including its Form 10-K for the fiscal year ended July 31, 2024 and Form 10-Q for the fiscal first quarter ended October 31, 2024. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250121301274/en/
Tim Steffensmeier, Vice President of Sales
PURE Bioscience, Inc.
Phone: 619-596-8600 Ext. 170
Source: PURE Bioscience, Inc.
FAQ
What is the new distribution agreement between PURE Bioscience (PURE) and Hydrite Chemical Company?
How does PURE Bioscience's SDC technology work?
What is the shelf life advantage of PURE's SDC technology?
How long has PURE Bioscience been working with Hydrite before this new agreement?
